137 related articles for article (PubMed ID: 16139303)
1. Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor.
Lobo SM; Orrico SR; Queiroz MM; Cunrath GS; Chibeni GS; Contrin LM; Cury PM; Burdmann EA; de Oliveira Machado AM; Togni P; De Backer D; Preiser JC; Szabó C; Vincent JL
J Surg Res; 2005 Dec; 129(2):292-7. PubMed ID: 16139303
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
Murakami K; Enkhbaatar P; Shimoda K; Cox RA; Burke AS; Hawkins HK; Traber LD; Schmalstieg FC; Salzman AL; Mabley JG; Komjáti K; Pacher P; Zsengellér Z; Szabó C; Traber DL
Shock; 2004 Feb; 21(2):126-33. PubMed ID: 14752285
[TBL] [Abstract][Full Text] [Related]
3. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.
Iványi Z; Hauser B; Pittner A; Asfar P; Vassilev D; Nalos M; Altherr J; Brückner UB; Szabó C; Radermacher P; Fröba G
Shock; 2003 May; 19(5):415-21. PubMed ID: 12744483
[TBL] [Abstract][Full Text] [Related]
4. Poly-ADP-ribose polymerase inhibition reduces mesenteric injury after cardiopulmonary bypass.
Szabó G; Seres L; Soós P; Flechtenmacher C; Zsengellér Z; Sack FU; Szabó C; Hagl S
Thorac Cardiovasc Surg; 2004 Dec; 52(6):338-43. PubMed ID: 15573274
[TBL] [Abstract][Full Text] [Related]
5. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
[TBL] [Abstract][Full Text] [Related]
6. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
[TBL] [Abstract][Full Text] [Related]
7. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
[TBL] [Abstract][Full Text] [Related]
8. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
[TBL] [Abstract][Full Text] [Related]
9. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage].
Fan HB; Wang YN; Geng DQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804
[TBL] [Abstract][Full Text] [Related]
10. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
11. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock.
Yuksel BC; Serdar SE; Tuncel A; Uzum N; Ataoglu O; Atan A; Hengirmen S; Iskit AB; Guc MO
Eur Surg Res; 2009; 43(2):219-27. PubMed ID: 19556798
[TBL] [Abstract][Full Text] [Related]
12. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.
Casey PJ; Black JH; Szabo C; Frosch M; Albadawi H; Chen M; Cambria RP; Watkins MT
J Vasc Surg; 2005 Jan; 41(1):99-107. PubMed ID: 15696051
[TBL] [Abstract][Full Text] [Related]
13. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
[TBL] [Abstract][Full Text] [Related]
14. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
16. The role of poly(ADP-ribose) synthetase inhibition on the intestinal mucosal barrier after thermal injury.
Avlan D; Taşkinlar H; Unlü A; Oztürk C; Cinel L; Nayci A; Cinel I; Aksöyek S
Burns; 2004 Dec; 30(8):785-92. PubMed ID: 15555790
[TBL] [Abstract][Full Text] [Related]
17. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury.
Stone DH; Conrad MF; Albadawi H; Entabi F; Stoner MC; Cambria RP; Watkins MT
Vasc Endovascular Surg; 2009; 43(5):444-51. PubMed ID: 19640911
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines.
Gangopadhyay NN; Luketich JD; Opest A; Visus C; Meyer EM; Landreneau R; Schuchert MJ
Cancer Invest; 2011 Nov; 29(9):608-16. PubMed ID: 22011283
[TBL] [Abstract][Full Text] [Related]
20. Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model.
Hamahata A; Enkhbaatar P; Lange M; Yamaki T; Sakurai H; Shimoda K; Nakazawa H; Traber LD; Traber DL
Burns; 2012 Dec; 38(8):1210-5. PubMed ID: 22995423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
